ArticleFrontiers in pharmacology2026

Dicaffeoylquinic acid alleviates alcoholic liver disease by targeting PLA2G4B and inhibiting the MAPK signaling pathway.

Linlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.